Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

China’s Fosun Pharma Targets $650 Million IPO With Prudential Insurance As Cornerstone Investor

Oct 23 2012

• By Jialing Dai

Related Content

With Pfizer As Cornerstone Investor, Will Shanghai Pharmaceutical Be Largest Pharma IPO Ever?

May 10 2011

Shanghai Fosun Omni Pharma Execs On The Market For Inhalation Products In China: An Interview With PharmAsia News (Part 2 of 2)

Sep 08 2008

China Distributor Consolidation Heats Up: Sinopharm Looks To Raise $440 Million Ahead Of Shanghai Pharma IPO

Apr 27 2011

Related Companies

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Henlius Biotech Co. Ltd.

Shanghai Pharmaceutical Group Co., Ltd

Sinopharm Group Co. Ltd.

CSPC Pharmaceutical Group Limited

Chindex International, Inc.

Tongjitang Chinese Medicines Co.

3SBio Inc.

ShangPharma Corporation

Simcere Pharmaceutical Group

Merck & Co., Inc.

Johnson & Johnson

Pfizer Inc.

Additional Topics

China Asia Pacific Emerging Markets BioPharmaceutical

More from China

More from Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window